The reticuloendotheliosis viruses (REV) are a family of highly related retroviruses isolated from gallinaceous birds. On the basis of sequence comparison and overall genome organization, these viruses are more similar to the mammalian type C retroviruses than to the avian sarcoma/leukemia viruses. The envelope of a member of the REV family, spleen necrosis virus (SNV), is about 50%o identical in amino acid sequence to the envelope of the type D simian retroviruses. Although SNV does not productively infect primate or murine cells, the receptor for SNY is present on a variety of human and murine cells. Moreover, interference assays show that the receptor for SNY is the same as the receptor for the type D simian retroviruses. We propose that adaptation of a mammalian type C virus to an avian host provided the REV progenitor.
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Spleen necrosis virus (SNV) is a type C retrovirus isolated from ducks that is capable of killing ducklings within a week of inoculation (35) and inducing immunodeficiency in older animals (38) . The virus is cytopathic to cultured chicken embryo fibroblasts and can productively infect a canine cell line (32, 33) . Phylogenetically, SNV is grouped among the avian reticuloendotheliosis virus (REV) subspecies, which also includes the defective, transforming virus REV-T and its replication-competent helper, REV-A (38) . SNV and REV-A share over 90% nucleic acid sequence homology across their genomes (24) and use a common receptor (8, 16) .
The predicted amino acid sequence of the envelope gene of REV-A has been reported to have about 42% amino acid identity with the env gene of the simian type D retroviruses and the type C baboon endogenous virus (BAEV) (18, 31) . Assays based on infection interference demonstrate that the simian type D retroviruses, BAEV, and the endogenous type C feline virus RD114 use a common receptor (29) . However, the gag and pol genes of the REV family are distinct from those of simian type D retroviruses and instead share homology with those of mammalian type C retroviruses (2, 3, 24, 37) . Despite the similarities in primary sequence of mammalian retroviruses and REV, REV cannot productively infect cells of murine or primate origin (14, 19) .
Here, we show that the REV receptor is present on both murine and human cell lines. These cells can be infected with retrovirus vectors that are packaged with REV Gag, Pol, and Env proteins. While this work was in progress, Koo et al. also reported that SNV can enter human as well as simian cells (19) . Furthermore, sequence analysis of SNV env reveals a greater predicted amino acid sequence homology with the simian type D retroviruses and BAEV than previous comparisons of REV-A to these simian retroviruses. Accordingly, preinfection of cells susceptible to REV infection with a simian type D virus will inhibit subsequent infection of REV-A by three orders of magnitude. This interference suggests that REV-A and SNV use the same receptor as the simian type D retroviruses and BAEV. On the basis of sequence similarities and utilization of a common receptor, * Corresponding author.
we propose that the progenitor of the avian REVs originated through the adaptive radiation of a BAEV-like mammalian retrovirus.
MATERIALS AND METHODS
Nomenclature. Plasmids have a small "p" before their name, while virus stocks derived from those plasmids do not (e.g., pLXSH and LXSH). Virus stocks are designated by the name of the plasmid used to derive the genome followed in parentheses by the type of envelope protein on the virion [e.g., LXSH(REV) is a retrovirus vector derived from transfection of pLXSH into a REV-packaging line]. Infected cells are designated by the name of the cell line followed by the name of the virus (e.g., D17/SNV).
Plasmids. pLXSH is a murine leukemia virus (MuLV)-based retroviral vector identical to pLXSN (22) except that it contains the hygromycin B phosphotransferase (hph) gene, which confers resistance to the drug hygromycin B in eukaryotic cells, in place of the neo gene of pLXSN. pSNV-hygro is an SNV-based vector derived from pJD216neo (11) . It contains the hph gene driven by the SNV LTR. pPB1l1 and pSW253 are complete proviral clones of SNV and REV-A, respectively (1, 5) . pSHRM-15 encodes a complete proviral clone of SRV-3 (25) .
Sequencing and analysis. The SNV env open reading frame and flanking sequences of pPB1O1 were cloned into pBluescriptKS+ (Stratagene Co., La Jolla, Calif.) and pTZ18R (Pharmacia). Subclones were generated by making nested unidirectional deletions commencing from the 5' portion of the env gene (17) . Single-stranded DNA was produced by using M13K07 helper phage and was the substrate for Sanger dideoxy sequencing (27) . Nucleotide oligomers corresponding to phage T3 and T7 RNA polymerase promoters and oligomers based on the REV-A env sequence (37) were used as primers in sequencing.
Sequence analyses were performed with the software package of the University of Wisconsin Genetics Computer Group (9), using the BestFit algorithm (28) 106 CEMx174/ SRV-3 cells and replated in a 100-mm-diameter plate containing DMEM plus 10% fetal calf serum and 10 ,ug of Polybrene per ml. After 2 days, the nonadherent CEMx174/ SRV-3 cells were removed and the monolayer was washed three times with phosphate-buffered saline. These cells, called D17/SRV-3, were passaged by trypsinization at least twice more before use. In addition, RNA derived from D17/SRV-3 cells does not contain a human T4-cell-specific message, CD4, which is expressed in CEMx174 and CEMx174/SRV-3 cells (data not shown).
COS-7 cells were transfected with DEAE-dextran and chloroquine as described previously (15) . All other transfections were done by the method of Chen and Okayama (4). Total cellular RNA was extracted by the acid guanidinium thiocyanate-phenol-chloroform protocol (6) . RNA blotting and analysis was done by standard techniques (26) .
Generation of viral stocks. Cell lines producing virally packaged vector were obtained by transfection of REV-Aor amphotropic MuLV (A-MuLV)-packaging cells lines (D17.2G and PA317, respectively) with pLXSH followed by selection for hygromycin B resistance. Virus was harvested from packaging cells which were stably transfected with the vector. Harvested viral supernatant was centrifuged to remove infected cells and stored at -80°C in small aliquots. Vector pseudotypes obtained include LXSH(REV) and LXSH(A-MuLV).
Another set of REV-A-packaged vectors was obtained by cotransfection of D17 cells with the SNV-based vector pSNV-hygro and pSW253. Viral supernatant was gathered on successive days after the appearance of Mn2+-dependent reverse transcriptase activity in the cell supernatant. This virus stock is designated REV-hygro.
Infections and virus titering. Cells were plated at 1 x 105 to 2 x 105 cells per well on a 12-well plate (22-mm diameter). RESULTS REV receptor appears on many mammalian cell types. Because SNV and REV-A do not productively infect human or murine cells, it was necessary to use a biological assay which is independent of virus production to detect the presence of the REV receptor on these cell types. To circumvent difficulties in the expression of SNV-based vectors in certain mammalian cell types (14) , virions were engineered that contained REV-A Gag, Pol, and Env proteins and that have packaged the genome of a defective murine retrovirus instead of an SNV provirus. The viral genome packaged in this system is the MuLV-based retrovirus vector LXSH. The virus stock, LXSH(REV), was harvested from the REV-A-packaging line D17.2G (12) , which is stably transfected with pLXSH. It has previously been shown that REV proteins can package MuLV-derived vectors 50% as efficiently as SNV-derived vectors in the absence of a competing SNV vector (13) .
The presence of the REV receptor on human and mouse cells was determined by the ability of LXSH(REV) to confer drug resistance after infection. The virus titer, measured by infection of each human and mouse cell line, was compared with the titer measured by parallel infection of a canine cell line (D17) that is permissive for REV infection (Table 1) . SNV glycosylation sites which nearly align with SRV-3 (within 3 amino acids) are denoted by X, and the site which does not align is denoted by 0. The cleavage between the SU and the TM proteins is marked with an asterisk. The immunosuppressive peptide is underlined.
( Table 1) . Moreover, the primary human skin fibroblast culture gave 59% as many colonies as D17 cells. This indicates that despite the block to productive infection of SNV in human cells, the receptor for SNV must exist on human cells. In addition, because the colonies can be grown for multiple generations, it is unlikely that there is a block to proviral integration.
In agreement with previous reports that indicated that NIH 3T3 cells could not be infected with SNV and that one of the blocks to infection may be at entry (14) SNV Env shares homology with Env of BAEV and simian type D retroviruses. Of those proteins which are common to all retroviruses, the envelope (Env) protein is the least conserved (10, 20) . Within the simian type D retrovirus receptor interference group, the conservation of amino acid identity between the Env proteins of the different members ranges from 48 to 87% (references 18, 23, and 34 and data not shown). We sequenced the env gene of an infectious molecular clone of SNV and determined the degree of similarity it shared with the Env proteins of other retroviruses that infect mammalian cells. We found that the predicted amino acid sequence of SNV Env is 49% identical to that of a prototypic simian type D virus, SRV-3 (Fig. 1) . When conservative amino acid changes are included in the alignment, there is 65% similarity between the two sequences. SNV Env is even more highly conserved with the squirrel monkey retrovirus (55% amino acid identity) and the type C BAEV (54% identity) ( Table 2 ). More importantly, however, the positions and occurrences of cysteines within the SNV Env are conserved among the Env proteins of the members of the simian type D virus group as well as the Env of the type C BAEV ( Fig. 1 and Table 2 ). This suggests that the tertiary structures of the Env proteins determined by disulfide bonds are probably similar among these simian viruses. In addition, there is a very strong conservation of the potential N-linked glycosylation sites between SNV Env and the Env proteins of the viruses in the simian type D retrovirus interference group.
Within Env, the transmembrane (TM) portion of the Env precursor is more conserved than the surface (SU) portion between SNV and the envelope of BAEV and the simian type D viruses ( Fig. 1 and data not shown) . The a Virus sequence information was obtained from the GenBank data base (Los Alamos National Laboratory). SRV-1, -2, and -3 (simian retrovirus serotypes 1, 2, and 3) and SMRV (squirrel monkey retrovirus) are type D retroviruses, whereas BAEV, GALV (gibbon ape leukemia virus), and Mo-MuLV (Moloney murine leukemia virus) are type C retroviruses.
b Alignments were performed by using the BestFit algorithm (28) in the University of Wisconsin Genetics Computer Group software package (9) . Gap weights = 5.00; gap length weights = 0.1.
c These ratios reflect the number of cysteins which align against the total number of SNV cysteines under the BestFit algorithm. The mature form of SNV Env glycoprotein contains a total of 23 residues in the SU and TM portions of the molecule and does not contain the N-terminal secretory leader sequence included in Fig. 1 .
d Putative N-linked glycosylation sites are those tripeptides of the sequence N-X-S or N-X-T, where X cannot be a proline residue. Sites are considered aligned when they occur within 3 residues under the amino acid alignment. retroviruses, and the regions which flank the immunosuppressive peptide (7, 31) . In contrast, SNV displays only 28% amino acid identity with Moloney murine leukemia virus (Mo-MuLV) and 30% with another type C primate retrovirus, gibbon ape leukemia virus. The limited homology observed with these type C viruses appears outside of the SU portion and is due to the highly conserved immunosuppressive peptide in the TM portions of the viruses (reference 31 and data not shown). The unusual degree of similarity of SNV Env with Env of the type D retroviruses and of BAEV, in fact, predicts a phylogeny that is distinct from pol-based trees which place SNV at a closer evolutionary distance to MuLVs than to the simian type D viruses or BAEV (10, 20) .
Interference of REV infection by preinfection of cells with SRV-3. Given the similarity in Env between SNV, BAEV, and the simian type D viruses, we wished to determine whether these viruses use the same receptor. Interference assays have been used to determine whether or not two retroviruses use the same receptor (29, 36) . Interference is thought to occur by the association of the endogenously expressed Env with the cellular receptor, thus reducing the amount of receptor that may function on the cell surface (36) . Preinfection of cells with SNV or REV-A will protect cells from superinfection by a REV-packaged vector through the endogenous production of retroviral Env (8, 16 Fig. 2 , this stock yielded 1.9
x 104 hygromycin-resistant colonies per ml of inoculum when D17 cells were infected. This same stock yielded only 15 hygromycin-resistant colonies per ml when it was used to infect D17 cells that were chronically infected with SNV. This confirms previous findings that REV-A and SNV use a common receptor (8, 16) .
The REV-hygro stock was also used to infect D17/SRV-3 cells. Preinfection of the D17 cells with SRV-3 reduced the number of hygromycin-resistant colonies to 15 per ml of REV-hygro (Fig. 2) . This indicates that SRV-3 interferes with REV infection and therefore implies that both viruses use the same receptor. In order to demonstrate that this interference was specific to vectors packaged with REV proteins, the titer of an amphotropic virus stock containing the MuLV vector LXSH was determined on D17, D17/SNV, and D17/SRV-3 cells. The titer of LXSH(MuLV) was not significantly affected by preinfection of the D17 cells with either SNV or SRV-3 (Fig. 2) . This indicates that the resistance to REV-hygro infection of D17 cells preinfected with SNV or SRV-3 is specific to the challenge virus.
DISCUSSION
The sequence of the env gene of SNV, an avian virus, reveals approximately 50% identity with the predicted amino acid sequences of both the simian type D retroviruses and BAEV. Cells preinfected with either SRV-3 or SNV are markedly less susceptible to superinfection when challenged by vectors packaged with REV proteins. The interference to infection suggests that these avian and simian viruses use an equivalent receptor. Consistent with this conclusion, we found that viral pseudotypes displaying a REV Env can infect human cells. We also find that REV-A pseudotypes can enter some murine cells. Blocks to productive infection of the virus in these mammalian cells, therefore, must occur at steps in the virus life cycle beyond virus entry.
The presence of a REV receptor on murine cells is somewhat surprising, because the simian type D viruses are restricted from entering mouse cells (29, 30) . On the other hand, pseudotypes made with the BAEV envelope can infect murine cells at low efficiency (30) . These inconsistencies in receptor tropism are probably due to subtle differences in the Env proteins of viruses in this interference group (29) . In addition to SNV Env and BAEV Env pseudotypes being able to enter mouse cells, the gag and pol gene products of the REVs and type C BAEV are more closely related to one another than they are to the type D simian retroviruses (2, 3, 24, 36, 37) .
These data imply a common evolutionary origin for SNV and BAEV that is distinct from the presumed recombinatorial origin of the simian type D retroviruses, which possess a mouse mammary tumor virus-like Gag and Pol (18, 31) . Unlike the REVs, BAEV is an endogenous virus and is therefore transmitted as a stable genetic element. Also, unlike SNV, BAEV displays no apparent pathogenesis to its host (36) . Because SNV is an exogenous and pathogenic retrovirus, we propose that the avian REVs are the result of an adaptive radiation of a BAEV-like, mammalian retrovirus to birds. Direct transmission of BAEV to the North American fowls which host the REV-like viruses seems unlikely, because both viral hosts are geographically isolated and the xenotropic host range of BAEV does not extend to avian cells in vitro (36) . Because the variability of BAEV is fixed as an endogenous element, the restriction of BAEV from avian cells precludes the possibility of a REV being the direct progenitor of BAEV. This restriction also suggests the existence of another type C virus, related to BAEV, which was the true REV progenitor. Given the potential of retroviruses to spread among similar host species, retroviral transmission across animal phyla has not been previously documented to have occurred in recent viral evolution. SNV may be exceptional in that regard.
